New prescription medications guidelines for weight loss released by American Gastroenterological Association

Written By : Isra Zaman

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-10-22 03:30 GMT | Update On 2022-10-22 03:30 GMT

Obesity is a medical condition in which too much body fat negatively impacts your health. It is healthy to have some body fat. In fact, a healthy level of body fat is needed to survive. But too much fat can be harmful to your body. Obesity is most often measured by body mass index (BMI), a calculation of body weight compared with height. BMI isn't the only way to measure healthy weight. For most adults trying to shed pounds diet and exercise mostly fail in the long term. Recently new evidence-based guidelines were released by American Gastroenterological Association strongly recommending that these patients with obesity use recently approved medications coupled together with lifestyle changes.

The following medications, paired with healthy eating and regular physical activity, are first-line medical options and result in moderate weight loss as noted as a percentage of body weight (reported as the difference compared to percent weight loss observed in the placebo group).

Semaglutide, weight loss percentage: 10.8%

Phentermine-topiramate ER, weight loss percentage: 8.5%

Liraglutide, weight loss percentage: 4.8%

Naltrexone-Bupropion ER, weight loss percentage: 3.0%

"These medications treat a biological disease, not a lifestyle problem. Obesity is a disease that often does not respond to lifestyle interventions alone in the long-term," says author Eduardo Grunvald."Using medications as an option to assist with weight loss can improve weight-related complications like joint pain, diabetes, fatty liver and hypertension."

Reference:

Eduardo Grunvald, et al,AGA Clinical Guidelines on Pharmacological Interventions for Adults with Obesity,JOURNAL:Gastroenterology

Full View

Article Source : Gastroenterology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Isra Zaman

Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

New prescription medications guidelines for weight loss released by American Gastroenterological Association

Similar News

Evidence-Based Recommendation by Indian Pediatric Experts on the Use of Acid-Reducing Medications in Children

Study Reveals Why Some People with Obesity Avoid Disease Through Genetic Mapping

Acupuncture May Ease Chronic Back Pain and Boost Function in Older Adults: Study Shows

India Sees Sharp Rise in Deaths from Lifestyle Diseases: Global Study Finds

WHO Updates Essential Medicines List, Adds Cancer, Diabetes and Obesity Drugs

Common Nasal Spray Cuts COVID Risk by Two-Thirds in Clinical Trial

Glipizide and Metformin FDC - Effective, Safe and Cost-Effective in T2D: Latest Indian Real-World Study

Study Reveals Potassium-Rich Foods May Lower Irregular Heartbeat Risk